Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1131 issues

How to Get Opsumit (macitentan) Covered by Blue Cross Blue Shield in Virginia: Complete PA Guide & Appeals Process

Answer Box: Getting Opsumit (macitentan) Covered by Blue Cross Blue Shield in Virginia Fastest Path: Opsumit requires prior authorization from Blue Cross Blue Shield in Virginia. Your pulmonologist must submit PA documentation including WHO Group 1 PAH diagnosis, step therapy compliance, and pregnancy testing records. If denied, Virginia offers external

Renewing Xospata (Gilteritinib) Approval with Blue Cross Blue Shield Michigan: Complete Timeline and Documentation Guide

Answer Box: Renewing Xospata Coverage in Michigan Most Blue Cross Blue Shield Michigan (BCBSM) Xospata prior authorizations require renewal every 6-12 months. Start the renewal process 14 days before expiration by submitting updated clinical documentation through the BCBSM provider portal. Required documents include: treatment response data, current FLT3 mutation status,

How to Get Kalydeco (ivacaftor) Covered by Blue Cross Blue Shield in Ohio: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Kalydeco Covered by Blue Cross Blue Shield in Ohio Kalydeco (ivacaftor) requires prior authorization from Blue Cross Blue Shield in Ohio. The fastest path to approval: (1) Confirm your CFTR mutation is responsive (G551D, R117H, or other FDA-approved variants), (2) Have your CF specialist submit a complete

How to Get Opsumit (Macitentan) Covered by Blue Cross Blue Shield in Georgia: Complete Appeals Guide with Forms and Deadlines

Quick Answer: Getting Opsumit Covered by Blue Cross Blue Shield in Georgia Getting Opsumit (macitentan) approved by Blue Cross Blue Shield in Georgia requires prior authorization with specific documentation. The fastest path: submit PA request through Anthem's Availity portal with PAH diagnosis, specialist prescriber, negative pregnancy test (if

How to Get Increlex (mecasermin) Covered by Blue Cross Blue Shield of Michigan: Prior Authorization Forms, Appeal Timeline, and State Review Process

Quick Answer: Blue Cross Blue Shield of Michigan requires prior authorization for Increlex (mecasermin) for severe primary IGF-1 deficiency in children ≥2 years old. Your pediatric endocrinologist must document height ≤-3.0 SD, low IGF-1 levels, and normal/elevated growth hormone. If denied, you have 127 days to file an

Do You Qualify for Breyanzi Coverage by Blue Cross Blue Shield in Washington? Decision Tree & Next Steps

Answer Box: Your Fastest Path to Breyanzi Coverage To get Breyanzi (lisocabtagene maraleucel) covered by Blue Cross Blue Shield in Washington: 1. Confirm eligibility: You need relapsed/refractory large B-cell lymphoma after ≥2 lines OR CLL/SLL after ≥2 lines including BTK and BCL-2 inhibitors 2. Submit prior authorization: Your

How to Get Tracleer (bosentan) Covered by Blue Cross Blue Shield in New York: Forms, Appeals & Contact Directory

Answer Box: Getting Tracleer Covered by BCBS New York Blue Cross Blue Shield New York requires prior authorization for Tracleer (bosentan) with mandatory REMS enrollment and specialty pharmacy dispensing. The fastest path: 1) Ensure your cardiologist/pulmonologist and you are enrolled in the Tracleer REMS program, 2) Complete baseline liver

If Abecma Isn't Approved by Blue Cross Blue Shield in Virginia: Formulary Alternatives & Exception Paths

Answer Box: Your Options When BCBS Virginia Denies Abecma If Blue Cross Blue Shield Virginia denies Abecma (idecabtagene vicleucel), Carvykti (ciltacabtagene autoleucel) is the primary formulary alternative CAR-T therapy for multiple myeloma. Both require prior authorization and similar clinical criteria. First step today: Contact your oncologist to discuss switching to

How to Get Retevmo (Selpercatinib) Covered by Blue Cross Blue Shield in North Carolina: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Retevmo Covered by BCBS North Carolina Blue Cross Blue Shield of North Carolina requires prior authorization for Retevmo (selpercatinib) for RET fusion-positive NSCLC and thyroid cancers. You'll need FDA-approved RET testing results, pathology reports, and clinical documentation. If denied, file internal appeals within 180 days,

How to Get Opfolda (miglustat) Covered by Blue Cross Blue Shield in New York: Complete Prior Authorization Guide with Appeals Process

Answer Box: Getting Opfolda Covered by Blue Cross Blue Shield in New York Eligibility: Adults with late-onset Pompe disease (≥40 kg) not improving on current enzyme replacement therapy. Fastest Path: Have your specialist submit prior authorization with ERT failure documentation through Blue Cross provider portal. First Step Today: Contact your